Cure rates obtained with five different Helicobacter pylori eradication protocols in patients with duodenal ulcer: A prospective, open-label, randomized study in a primary care setting in Turkey
CURRENT THERAPEUTIC RESEARCH-CLINICAL AND EXPERIMENTAL, vol.62, no.6, pp.462-472, 2001 (SCI-Expanded, Scopus)
- Publication Type: Article / Article
- Volume: 62 Issue: 6
- Publication Date: 2001
- Doi Number: 10.1016/s0011-393x(01)80057-6
- Journal Name: CURRENT THERAPEUTIC RESEARCH-CLINICAL AND EXPERIMENTAL
- Journal Indexes: Science Citation Index Expanded (SCI-EXPANDED), Scopus
- Page Numbers: pp.462-472
- Middle East Technical University Affiliated: No
Abstract
Background: Helicobacter py[ori is the main causative agent in peptic ulcer disease. Duodenal ulcer disease is a chronic, recurring condition, and the risk of recurrence and complications does not diminish over time unless H pylori is eradicated. Several treatment protocols exist to eradicate H pylori, but their efficacy and costs vary. Because of regional variations in bacterial resistance and in treatment costs, primary care physicians must use the most appropriate protocol for their own region and population.